文献速递心力衰竭与心肌病

葡萄牙≥50岁人群心力衰竭患病率与表型:PORTHOS研究

Heart failure in the Portuguese population aged ≥50 years: prevalence and phenotypes in the PORTHOS study.
PubMed 文献 · Eur Heart J · 2026-01-01

PORTHOS为葡萄牙基于社区的横断面研究,纳入6189名≥50岁成人,采用两阶段设计,以NT-proBNP筛查联合超声心动图确诊心力衰竭。估算心力衰竭患病率为16.54%,其中93.4%为射血分数保留的心力衰竭,90%既往未被诊断。

要点

  • ≥50岁葡萄牙社区成人心衰患病率约六分之一,90%既往未诊断。
  • HFpEF占心衰病例93.4%,与高龄、女性、糖尿病、房颤、血脂异常相关。
  • NT-proBNP筛查联合超声心动图有助于老龄人群心衰早期识别。

核心结论

  • 心力衰竭影响约六分之一的葡萄牙≥50岁成人。
  • HFpEF占心衰病例90%以上,且绝大多数既往未被诊断。
  • 基于NT-proBNP的筛查联合超声心动图评估有助于改善老龄人群心衰的早期检出。

研究设计与样本

  • PORTHOS为基于社区的横断面研究,采用两阶段设计。
  • 第一阶段随机选取≥50岁社区成人,进行结构化访谈和NT-proBNP即时检测。
  • NT-proBNP≥125 pg/mL和/或自报心衰诊断者,以及5%筛查阴性随机样本进入第二阶段。
  • 第二阶段进行临床评估、心电图和超声心动图检查。

主要发现

  • 6189名参与者中2249人筛查阳性,1136人被诊断为心力衰竭。
  • 估算心力衰竭患病率为16.54%,随年龄增长从50-59岁的4.01%升至≥70岁的30.68%。
  • 女性患病率高于男性,为21.00%对10.47%。
  • 93.4%的病例为HFpEF,90%既往未被诊断。
  • HFpEF与高龄、女性、2型糖尿病、心房颤动和血脂异常独立相关。

关键数值与推荐

  • 心力衰竭诊断需存在症状、NT-proBNP≥125 pg/mL及超声心动图标准。
  • 心力衰竭定义依据2021年ESC和HFA-PEFF指南。
  • NT-proBNP≥125 pg/mL作为第一阶段的筛查阳性阈值。

临床怎么用

  • 对≥50岁社区人群可考虑采用NT-proBNP筛查结合超声心动图评估的策略。
  • 对老年女性合并糖尿病、房颤或血脂异常者需警惕HFpEF可能。
  • 大量未诊断心衰提示应加强社区层面主动筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Heart failure (HF) is a major global health burden, yet its true prevalence remains uncertain due to heterogeneous study designs and evolving diagnostic criteria. The Portuguese Heart Failure Prevalence Observational Study (PORTHOS) aimed to estimate the prevalence and phenotypic distribution of HF in community-dwelling adults aged ≥50 years in mainland Portugal. METHODS: PORTHOS was a cross-sectional, population-based study with a two-stage design. Stage 1 randomly selected community-dwelling individuals aged ≥50 years via structured interviews and point-of-care N-terminal pro-B-type natriuretic peptide (NT-proBNP) testing. Individuals with NT-proBNP ≥125 pg/mL and/or a self-reported HF diagnosis, plus a random 5% of screen-negatives, proceeded to stage 2. This confirmatory stage included clinical assessment, electrocardiogram, and echocardiography. HF diagnosis required the presence of symptoms, NT-proBNP ≥125 pg/mL, and echocardiographic criteria. HF was defined as per the 2021 ESC and HFA-PEFF guidelines. RESULTS: Of 6189 participants, 2249 screened positive and 1136 were diagnosed with HF. The estimated HF prevalence was 16.54%, increasing with age (from 4.01% in 50-59 years old to 30.68% in those ≥70) and higher in females than males (21.00% vs 10.47%). Notably, 93.4% had HF with preserved ejection fraction (HFpEF), and 90% were previously undiagnosed. HFpEF was independently associated with older age, female sex, type 2 diabetes, atrial fibrillation, and dyslipidaemia. CONCLUSIONS: HF affects approximately one in six Portuguese adults aged ≥50 years, with HFpEF accounting for over 90% of cases, most previously undiagnosed. These findings support NT-proBNP-based screening combined with echocardiographic evaluation to improve early HF detection in ageing populations.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Baptista, Rodrigues, Bernardo, et al. Heart failure in the Portuguese population aged ≥50 years: prevalence and phenotypes in the PORTHOS study. Eur Heart J. 2026. PMID: 41641552. doi:10.1093/eurheartj/ehag030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。